Beihan Wang,Elbert Chin,Francisco Xavier Talamas,Jim LI
申请号：
BRPI0920513
公开号：
BRPI0920513A2
申请日:
2009.09.18
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
Compounds having the formula I wherein R1, R2a, R2b, R2c, R3, Y and p are as defined herein and C2-C3 is a single or double bond are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
